Alaunos Therapeutics Financial Overview
Alaunos Therapeutics's market cap is currently $8.93M. The company's EPS TTM is $-2.922; its P/E ratio is -1.72; Alaunos Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
